157 related articles for article (PubMed ID: 19908114)
1. Impact of main bronchial lymph node involvement in pathological T1-2N1M0 non-small-cell lung cancer: multi-institutional survey by the Japan National Hospital Study Group for Lung Cancer.
Maeda H; Fukai S; Matsumura A; Kawashima O; Watanabe T; Yamanda T; Okabayashi K; Fujita Y; Tamura A; Kawahara M
Gen Thorac Cardiovasc Surg; 2009 Nov; 57(11):599-604. PubMed ID: 19908114
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung.
Matsuoka K; Sumitomo S; Misaki N
J Thorac Oncol; 2007 Dec; 2(12):1098-102. PubMed ID: 18090581
[TBL] [Abstract][Full Text] [Related]
3. Extent of lung resection in non-small lung cancer with interlobar lymph node involvement.
Gunluoglu MZ; Demir A; Turna A; Sansar D; Melek H; Dincer SI; Gurses A
Ann Thorac Cardiovasc Surg; 2011; 17(3):229-35. PubMed ID: 21697782
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
[TBL] [Abstract][Full Text] [Related]
5. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
[TBL] [Abstract][Full Text] [Related]
6. Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis.
Kuroda H; Sakao Y; Mun M; Uehara H; Nakao M; Matsuura Y; Mizuno T; Sakakura N; Motoi N; Ishikawa Y; Yatabe Y; Nakagawa K; Okumura S
PLoS One; 2015; 10(8):e0134674. PubMed ID: 26247881
[TBL] [Abstract][Full Text] [Related]
7. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.
Zhang YK; Chai ZD; Tan LL; Wang ZY; Chen ZJ; Le HB; Zhu WY
World J Surg Oncol; 2017 Mar; 15(1):64. PubMed ID: 28302176
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
[TBL] [Abstract][Full Text] [Related]
9. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases.
Yoshino I; Nakanishi R; Osaki T; Takenoyama M; Taga S; Hanagiri T; Yasumoto K
Chest; 1999 Jul; 116(1):144-9. PubMed ID: 10424518
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
[TBL] [Abstract][Full Text] [Related]
11. Survival impact of node zone classification in resected pathological N2 non-small cell lung cancer.
Baba T; Uramoto H; Kuwata T; Chikaishi Y; Nakagawa M; So T; Hanagiri T; Tanaka F
Interact Cardiovasc Thorac Surg; 2012 Jun; 14(6):760-4. PubMed ID: 22374294
[TBL] [Abstract][Full Text] [Related]
12. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
13. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
15. Mediastinal lymph-nodes metastasis beyond the lobe-specific: an independent risk factor toward worse prognoses.
Sun Y; Gao W; Zheng H; Jiang G; Chen C; Zhang L
Ann Thorac Cardiovasc Surg; 2014; 20(4):284-91. PubMed ID: 23774619
[TBL] [Abstract][Full Text] [Related]
16. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
Park S; Cho S; Yum SW; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
[TBL] [Abstract][Full Text] [Related]
18. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
19. Prognostic evaluation of nodal staging based on the new IASLC lymph node map for lung cancer.
Takamochi K; Oh S; Suzuki K
Thorac Cardiovasc Surg; 2010 Sep; 58(6):345-9. PubMed ID: 20824587
[TBL] [Abstract][Full Text] [Related]
20. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
